AskMed

Chorionic Villus Sampling (CVS): Timing, Risks and Results

Chorionic villus sampling (CVS) is a prenatal test that takes a small sample of cells from the placenta, usually between 11 and 14 weeks of pregnancy, and checks them for chromosomal and genetic conditions such as Down syndrome, Edwards syndrome, Patau syndrome, sickle cell disease, thalassemia and cystic fibrosis. Unlike a screening test, which only gives a chance, CVS gives a definite answer for about 99 in 100 women. It is offered after a higher-chance screening result or when a condition runs in the family, and having it is always your choice. This guide covers why CVS is offered, how it is done through the abdomen or the cervix, what the results show, its miscarriage risk next to amniocentesis in the latest meta-analyses, its limits, and how it fits with NIPT and other screening. Every figure links to the guideline or study it comes from.

What is chorionic villus sampling?

Chorionic villus sampling is a diagnostic test in which a doctor removes a small sample of cells from the placenta, the organ that links the mother's blood supply with the baby's, and sends it to a laboratory for chromosomal or genetic testing. The cells come from the chorionic villi, tiny finger-like projections of the placenta, and the NHS Fetal Anomaly Screening Programme notes that in most cases the placental DNA is the same as the baby's DNA. The American College of Obstetricians and Gynecologists (ACOG), in Practice Bulletin 162, describes diagnostic testing as intended to determine, with as much certainty as possible, whether a specific genetic disorder is present, and states that amniocentesis or CVS is needed to definitively diagnose most genetic disorders. That is the key difference from screening tests such as the combined test or NIPT, which estimate a chance but never give a diagnosis.

11–14weeks: when CVS is usually done (NHS)
~3 daysto the rapid result; the full result takes about 2 weeks
99 in 100women get a definite result (NHS)
<1 in 200chance of miscarriage in most pregnancies (NHS)

CVS is not a routine pregnancy test, and MedlinePlus, the US National Library of Medicine's health site, describes it as a test for people at higher risk. Because the sample comes from the placenta rather than from the fluid around the baby, CVS can be done several weeks earlier than amniocentesis, which is its main advantage: an answer in the first trimester rather than the second.

Why is CVS offered, and who has it?

CVS is offered when there is a higher chance that the baby has a chromosomal or genetic condition, not as a routine test, according to the NHS and MedlinePlus. The most common reason is a higher-chance screening result for Down syndrome, Edwards syndrome or Patau syndrome. In England, a higher-chance result from the combined or quadruple test means a chance of 1 in 150 or greater, and NHS England says about 3 in every 100 screening results fall into that group. The other reasons the NHS lists are a previous pregnancy affected by a genetic condition and a family history of a condition such as sickle cell disease, thalassemia, cystic fibrosis or muscular dystrophy. MedlinePlus adds being 35 or older. ACOG and the Society for Maternal-Fetal Medicine go further in Practice Bulletin 226: all patients should be offered both screening and diagnostic tests, and all have the right to accept or decline testing after counseling.

Whether to have CVS is a personal decision. The NHS points out that most conditions CVS can find have no cure, so some parents want the result to prepare for the baby's care, some to decide whether to continue the pregnancy, and some choose not to test at all. A midwife, obstetrician or genetic counselor should explain what the test can and cannot tell you before you decide.

When is CVS done, and how is the sample taken?

CVS is usually done between 11 and 14 weeks of pregnancy, according to the NHS, though it can be done later if needed; MedlinePlus gives a window of the 10th to the 13th week. It is not done earlier because of a link with limb problems when the test was done very early: in a 1991 report in The Lancet, Firth and colleagues found 5 babies with severe limb abnormalities among 289 pregnancies sampled at 56 to 66 days of gestation, about 8 to 9 weeks. MedlinePlus still lists limb defects as a very rare risk of CVS. The procedure itself takes about 10 minutes and the whole appointment about 30 minutes in the NHS description, and an ultrasound scan guides the needle or tube the whole time so that nothing enters the amniotic sac or touches the baby. Afterward, the NHS says you are usually watched for up to an hour, and you should arrange for someone to drive you home.

Usual timing of each test (weeks) Combined test 10–14 CVS 11–14 Quadruple test 14–20 Amniocentesis 15–20 Anomaly scan 18–21 10 12 14 16 18 20 22
Usual windows in the NHS pathway: screening tests in light blue, the two diagnostic tests in blue, and the mid-pregnancy anomaly scan in teal. CVS and amniocentesis can be done later when needed. Sources: NHS England screening leaflet (2026), NHS CVS, amniocentesis and 20-week scan pages.

Transabdominal vs transcervical CVS

In transabdominal CVS, the skin of the abdomen is cleaned and numbed with a local anesthetic, and a needle is guided through the abdomen into the placenta to draw out a small sample. In transcervical CVS, a thin tube or small forceps passes through the vagina and cervix to the placenta, which the NHS says feels similar to a cervical screening test. The NHS calls the transabdominal route the most common one and usually preferred because it is often easier, with the transcervical route used when the placenta is easier to reach that way; MedlinePlus, a US source, calls the transcervical route the most common, so practice differs between countries and units. Transcervical CVS is more likely to cause vaginal bleeding straight afterward, in about 1 in 10 women. In a Cochrane review of five trials with 7,978 women (Alfirevic 2017), there was no clear difference in pregnancy loss between the two routes, but the transcervical approach failed to obtain a sample more often (2.0% vs 1.1%).

Before and after the procedure

You can usually eat and drink as normal beforehand, and you may be asked not to empty your bladder for a few hours, because a full bladder can make the test easier. If your blood group is RhD negative, the NHS says you will be offered an anti-D immunoglobulin injection to stop your immune system making antibodies against the baby's blood, and you will have a blood test first if your blood group isn't known. Cramps like period pain and light spotting for a few hours afterward are normal. The NHS suggests paracetamol (acetaminophen) for discomfort, says ibuprofen and aspirin are not recommended, and advises avoiding strenuous activity for the rest of the day. Contact your midwife or the hospital straight away if you have:

What do CVS results show?

CVS results usually come in two stages. The NHS England leaflet for parents says you will usually receive a rapid CVS result in about 3 days, which checks for the conditions you were screened for, and a second, more detailed result after about 2 weeks. The NHS says CVS gives a definite result for about 99 in 100 women, and most results show that the baby does not have the condition the test was looking for. A result showing the baby does not have the conditions tested for rules out most of them, but MedlinePlus cautions that a normal result does not guarantee that the baby won't have any health problems, because CVS answers only the questions the laboratory was asked. If the rapid result and an earlier ultrasound scan both show a condition, the NHS says the options are discussed straight away; if the scan found nothing unexpected, it recommends waiting for the detailed result before deciding whether to end the pregnancy.

Sometimes there is no clear answer at first. The NHS says about 1 in 100 samples is unsuitable for testing, because too few cells were taken or the sample was contaminated with the mother's cells, and the NHS England leaflet says up to 6 in 100 women having CVS or amniocentesis are offered a second procedure, either a repeat CVS or an amniocentesis a few weeks later. A positive result also needs explaining: ACOG notes that many genetic disorders have a broad range of presentations and that genetic test results cannot predict all outcomes, so a fetal medicine specialist or genetic counselor goes through what it means for your baby. Your options are to continue the pregnancy and prepare for the baby's care, or to end it, and the NHS points to support from specialists and charities whichever you choose.

What is the miscarriage risk of CVS compared with amniocentesis?

The miscarriage risk after CVS is small and similar to the risk after amniocentesis. The NHS puts the chance of miscarriage after CVS at under 1 in 200 for most pregnancies and about 1 in 100 for twins and other multiple pregnancies, and gives about 1 in 200 for amniocentesis. Most of these miscarriages happen within 3 days of the procedure, though some happen up to 2 weeks later, and it is hard to tell which would have happened anyway. Meta-analyses that compare tested women with similar untested women put the added risk lower still. Akolekar and colleagues (Ultrasound in Obstetrics & Gynecology, 2015) estimated a procedure-related risk of 0.22% for CVS and 0.11% for amniocentesis. An updated analysis by Salomon and colleagues in 2019, covering 13,011 CVS and 63,723 amniocentesis procedures in controlled studies, found 0.20% for CVS and 0.30% for amniocentesis, and the confidence interval for CVS included zero.

CVS Amniocentesis Sample Placenta cells Amniotic fluid Usual timing 11–14 weeks 15–20 weeks First result About 3 days About 3 days Full result About 2 weeks About 2 weeks Miscarriage risk quoted by the NHS Under 1 in 200 About 1 in 200 Added risk, Salomon 2019 meta-analysis 0.20% 0.30% Added risk, Akolekar 2015 meta-analysis 0.22% 0.11%
Timing and results from NHS England and the NHS; "added risk" is the procedure-related risk of miscarriage from the two meta-analyses, over and above the loss rate in similar untested pregnancies.

When the 2019 analysis kept only studies whose tested and untested groups had a similar chance of a chromosomal condition, the procedure-related risk was −0.11% for CVS and 0.12% for amniocentesis, which the authors called negligible. Background loss also differs: in that analysis, 1.39% of pregnancies miscarried before 24 weeks after CVS, but so did 1.23% of the untested comparison pregnancies, so most losses after CVS were not caused by the test. The route may matter more than the test: the 2017 Cochrane review found no clear difference between transabdominal CVS and second-trimester amniocentesis in total pregnancy loss (6.3% vs 7%), while transcervical CVS may carry a higher risk of loss than amniocentesis, though those results were heterogeneous. For twins, the NHS England leaflet says the risk is about twice that of a single pregnancy and that the test should be done in a specialist unit.

What are the limits of CVS?

The main limit of CVS is that it tests the placenta rather than the baby directly, and occasionally the two differ. This is called confined placental mosaicism: some or all of the cells in the placenta carry a chromosome change that the baby does not have. In a 2014 review of 52,673 CVS samples analyzed over 13 years at one Italian laboratory, Grati found chromosomal mosaicism in 1,136 samples (1.81%). Among 886 mosaic cases checked further with amniocentesis, the change was confirmed in the baby in 12.8%, called true fetal mosaicism, and the rest were confined to the placenta. When this happens, the NHS England leaflet says a further test on the original sample may be needed, which takes about two weeks, and in a very small number of cases amniocentesis is offered to test the baby's own DNA. CVS also cannot look for every condition, and the NHS says a conclusive result is not always possible.

A mosaic result is where the questions pile up: which chromosome is involved, which layer of the placenta carries it, what the scan shows, and whether amniocentesis should follow. Grati's data show that the chance of the change being confirmed in the baby varies widely with exactly those details. AskMed is a medical question app made for doctors, nurses, pharmacists, medical students and researchers. Instead of answering from memory, it searches journals, clinical guidelines and drug labels first, then writes an answer with a link after every claim. Ask it what a mosaic trisomy on CVS with a normal ultrasound means and when amniocentesis is advised, and it sets out what the guidelines and laboratory studies say, with each source one tap away, so you can read them before you see the fetal medicine team.

Ask AskMed what an unclear CVS result means:

How does CVS fit with NIPT and other screening?

CVS is a diagnostic step that usually follows screening rather than replacing it. In England, screening for Down syndrome, Edwards syndrome and Patau syndrome starts with the combined test, a blood test between 10 and 14 weeks plus an ultrasound scan between 11 and 14 weeks, or the quadruple blood test between 14 and 20 weeks for those tested later. A higher-chance result, 1 in 150 or greater, leads to three choices, according to NHS England: no further testing, NIPT, or a diagnostic test such as CVS or amniocentesis. NIPT, non-invasive prenatal testing, uses placental DNA circulating in the mother's blood, so it carries no miscarriage risk, but it is still a screening test. After a higher-chance NIPT result, the NHS Fetal Anomaly Screening Programme handbook recommends offering prenatal diagnosis, such as CVS or amniocentesis, to confirm it. In the US, ACOG and SMFM updated Practice Bulletin 226 in 2020 to expand guidance on cfDNA screening, another name for NIPT, for all patients, whatever their age or baseline risk.

  1. Screening: combined test at 10 to 14 weeks, or quadruple test at 14 to 20 weeks. It gives a chance, not a diagnosis.
  2. Higher-chance result: 1 in 150 or greater, about 3 in 100 results. You choose: no more tests, NIPT, or a diagnostic test.
  3. NIPT (optional): a blood test of placental DNA, more accurate than the first screen but still screening.
  4. Diagnosis: CVS from 11 weeks or amniocentesis from 15 weeks gives a definite answer.
Where CVS sits in the NHS screening pathway for Down, Edwards and Patau syndromes. Sources: NHS England screening leaflet (2026) and FASP handbook (2026).

Because NIPT and CVS both read placental DNA, confined placental mosaicism can affect both, and Grati's review discusses it as a source of false NIPT results; the FASP handbook adds that NIPT is less accurate after a very high chance result for Edwards or Patau syndrome. That is why a higher-chance NIPT result is confirmed with a diagnostic test before any decision is made. Choosing between NIPT, CVS and amniocentesis after a higher-chance result means weighing how early you want an answer, how certain it needs to be and how much risk you accept, and the figures come from sources that don't always use the same terms. In AskMed you can ask, for example, how CVS at 12 weeks compares with NIPT followed by amniocentesis after a 1 in 90 combined test result, and get the NHS, ACOG and meta-analysis figures side by side with their links, ready to take to your midwife, obstetrician or genetic counselor.

Compare your testing options in AskMed:

Frequently asked questions

Is chorionic villus sampling painful?

The NHS describes CVS as uncomfortable rather than painful. A local anesthetic is usually used for the abdominal route, and the cervical route feels similar to a cervical screening test. Cramps like period pain and light spotting for a few hours afterward are normal.

How long do CVS results take?

A rapid result for the conditions you were screened for usually comes in about 3 days, and the full, more detailed result in about 2 weeks. If confined placental mosaicism is suspected, a further test on the sample takes about another two weeks.

Is CVS or amniocentesis safer?

Their risks are similar. The NHS quotes under 1 in 200 for CVS and about 1 in 200 for amniocentesis, and a 2019 meta-analysis put the added, procedure-related risk at 0.20% for CVS and 0.30% for amniocentesis. CVS gives an answer earlier; amniocentesis is done from 15 weeks.

Can CVS detect spina bifida?

No. CVS looks at chromosomes and genes, and MedlinePlus says it does not diagnose or screen for neural tube defects such as spina bifida. The NHS 20-week scan, usually at 18 to 21 weeks, checks for open spina bifida.

What does mosaicism on a CVS result mean?

It means some cells in the sample carry a chromosome change and others don't. Most often the change is confined to the placenta and the baby's chromosomes are normal, but sometimes the baby carries it too, so further testing of the sample or an amniocentesis may be offered to check the baby's own DNA.

Sources

  1. NHS. Chorionic villus sampling (CVS), including What happens, Results and Complications. Reviewed January 2023.
  2. NHS England. Chorionic villus sampling (CVS) and amniocentesis: information for parents. Updated March 2026.
  3. NHS England. Screening tests for you and your baby: Down's, Edwards' and Patau's syndromes. Updated September 2026.
  4. NHS England. Fetal anomaly screening programme handbook: screening for Down's, Edwards' and Patau's syndromes. Updated September 2026.
  5. NHS. Amniocentesis and 20-week screening scan.
  6. MedlinePlus, US National Library of Medicine. Chorionic Villus Sampling (CVS). Updated September 2024.
  7. American College of Obstetricians and Gynecologists. Practice Bulletin No. 162: Prenatal Diagnostic Testing for Genetic Disorders. Obstet Gynecol. 2016;127(5):e108-e122.
  8. ACOG and Society for Maternal-Fetal Medicine. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin No. 226. Obstet Gynecol. 2020;136(4):e48-e69.
  9. Akolekar R, Beta J, Picciarelli G, Ogilvie C, D'Antonio F. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015;45(1):16-26.
  10. Salomon LJ, Sotiriadis A, Wulff CB, Odibo A, Akolekar R. Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis. Ultrasound Obstet Gynecol. 2019;54(4):442-451.
  11. Alfirevic Z, Navaratnam K, Mujezinovic F. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev. 2017;9:CD003252.
  12. Grati FR. Chromosomal mosaicism in human feto-placental development: implications for prenatal diagnosis. J Clin Med. 2014;3(3):809-837.
  13. Firth HV, Boyd PA, Chamberlain P, et al. Severe limb abnormalities after chorion villus sampling at 56-66 days' gestation. Lancet. 1991;337(8744):762-763.

Cited medical answers
you can trust.

AskMed on iPhone, iPad, Android and the web.